CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS: Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial Tricoci, P., Chen, E., Neely, M. L., Warner, A., Wong, P. H., Sinnaeve, P., Wallentin, L., Jennings, L. K., Storey, R. F., Aylward, P. E., White, H. D., Van de Werf, F., Armstrong, P. W., Held, C., Valgimigli, M., Harrington, R. A., Strony, J., Mahaffey, K. W., Moliterno, D. J. LIPPINCOTT WILLIAMS & WILKINS. 2013

View details for Web of Science ID 000332162907012